These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37540490)
1. FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination. Dong B; Song X; Wang X; Dai T; Wang J; Yu Z; Deng J; Evers BM; Wu Y Mol Cancer Res; 2023 Dec; 21(12):1303-1316. PubMed ID: 37540490 [TBL] [Abstract][Full Text] [Related]
2. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression. Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032 [TBL] [Abstract][Full Text] [Related]
3. The ubiquitin E3 ligase SCF-FBXO24 recognizes deacetylated nucleoside diphosphate kinase A to enhance its degradation. Chen W; Xiong S; Li J; Li X; Liu Y; Zou C; Mallampalli RK Mol Cell Biol; 2015 Mar; 35(6):1001-13. PubMed ID: 25582197 [TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells. Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993 [TBL] [Abstract][Full Text] [Related]
5. LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity. Lan H; Tan M; Zhang Q; Yang F; Wang S; Li H; Xiong X; Sun Y Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12311-12320. PubMed ID: 31152129 [TBL] [Abstract][Full Text] [Related]
6. FOXK2 targeting by the SCF-E3 ligase subunit FBXO24 for ubiquitin mediated degradation modulates mitochondrial respiration. El-Mergawy R; Chafin L; Ovando-Ricardez JA; Rosas L; Tsai M; Rojas M; Mora AL; Mallampalli RK J Biol Chem; 2024 Jun; 300(6):107359. PubMed ID: 38735474 [TBL] [Abstract][Full Text] [Related]
7. E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC. Tang F; Lu C; He X; Lin W; Xie B; Gao X; Peng Y; Yang D; Sun L; Weng L Cell Rep; 2023 Dec; 42(12):113477. PubMed ID: 37979167 [TBL] [Abstract][Full Text] [Related]
8. SCF-FBXO24 regulates cell proliferation by mediating ubiquitination and degradation of PRMT6. Chen W; Gao D; Xie L; Wang A; Zhao H; Guo C; Sun Y; Nie Y; Hong A; Xiong S Biochem Biophys Res Commun; 2020 Sep; 530(1):75-81. PubMed ID: 32828318 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance. Ren C; Han X; Lu C; Yang T; Qiao P; Sun Y; Yu Z Cell Death Differ; 2022 Feb; 29(2):381-392. PubMed ID: 34465889 [TBL] [Abstract][Full Text] [Related]
10. F-box only protein 9 and its role in cancer. Hussain S; Dong J; Ma X; Li J; Chen S; Clement A; Liu H Mol Biol Rep; 2022 Feb; 49(2):1537-1544. PubMed ID: 35025031 [TBL] [Abstract][Full Text] [Related]
11. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Zhao D; Zheng HQ; Zhou Z; Chen C Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041 [TBL] [Abstract][Full Text] [Related]
12. Biological roles of LSD1 beyond its demethylase activity. Gu F; Lin Y; Wang Z; Wu X; Ye Z; Wang Y; Lan H Cell Mol Life Sci; 2020 Sep; 77(17):3341-3350. PubMed ID: 32193608 [TBL] [Abstract][Full Text] [Related]
13. The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling. Yang Y; Hao X; Zhang J; Gao T; Huo M; Liu W; Hu T; Ma T; Yuan B; Zhang M; Teng X; Yu H; Huang W; Wang Y Cancer Lett; 2024 Sep; 600():217157. PubMed ID: 39127340 [TBL] [Abstract][Full Text] [Related]
14. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. Liu J; Feng J; Li L; Lin L; Ji J; Lin C; Liu L; Zhang N; Duan D; Li Z; Huang B; Zhang Y; Lu J EMBO Rep; 2020 Feb; 21(2):e48597. PubMed ID: 31833203 [TBL] [Abstract][Full Text] [Related]
15. The R251Q mutation of LSD1 promotes invasion and migration of luminal breast cancer cells. Zhang Y; Wu T; Wang Y; Zhao X; Zhao B; Zhao X; Zhang Q; Jin Y; Li Z; Hu X Int J Biol Macromol; 2020 Dec; 164():4000-4009. PubMed ID: 32882276 [TBL] [Abstract][Full Text] [Related]
16. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells. Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527 [TBL] [Abstract][Full Text] [Related]
17. OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis. Gong Z; Li A; Ding J; Li Q; Zhang L; Li Y; Meng Z; Chen F; Huang J; Zhou D; Hu R; Ye J; Liu W; You H Adv Sci (Weinh); 2021 Aug; 8(15):e2004504. PubMed ID: 34050636 [TBL] [Abstract][Full Text] [Related]
18. Histone demethylase LSD2 acts as an E3 ubiquitin ligase and inhibits cancer cell growth through promoting proteasomal degradation of OGT. Yang Y; Yin X; Yang H; Xu Y Mol Cell; 2015 Apr; 58(1):47-59. PubMed ID: 25773598 [TBL] [Abstract][Full Text] [Related]
19. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation. Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319 [TBL] [Abstract][Full Text] [Related]
20. The histone demethylase LSD1/KDM1A promotes the DNA damage response. Mosammaparast N; Kim H; Laurent B; Zhao Y; Lim HJ; Majid MC; Dango S; Luo Y; Hempel K; Sowa ME; Gygi SP; Steen H; Harper JW; Yankner B; Shi Y J Cell Biol; 2013 Nov; 203(3):457-70. PubMed ID: 24217620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]